Private equity firm Hellman & Friedman is cutting its holdings in
- Sale of 1.5 million shares in health-care technology firm coming at a discount of as much as 14.7% to Wednesday’s closing price of $58.62
- Offering is fully subscribed following an earlier confidential marketing effort, said the people, who asked not to be identified because the information is private
- A spokesperson for Hellman & Friedman declined to comment; a representative for Claritev didn’t immediately respond to requests for comment ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
